相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Imaging neurodegeneration in Down syndrome: brain templates for amyloid burden and tissue segmentation
Patrick J. Lao et al.
BRAIN IMAGING AND BEHAVIOR (2019)
Comparison of longitudinal Aβ in nondemented elderly and Down syndrome
Dana L. Tudorascu et al.
NEUROBIOLOGY OF AGING (2019)
Delineating the topography of amyloid-associated cortical atrophy in Down syndrome
Elijah Mak et al.
NEUROBIOLOGY OF AGING (2019)
Tau PET Imaging for Staging of Alzheimer's Disease in Down Syndrome
Michael S. Rafii
DEVELOPMENTAL NEUROBIOLOGY (2019)
Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease
Ann D. Cohen et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2019)
Frontal cortex and striatal cellular and molecular pathobiology in individuals with Down syndrome with and without dementia
Sylvia E. Perez et al.
ACTA NEUROPATHOLOGICA (2019)
Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-beta Burden in Down Syndrome
Patrick J. Lao et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Infrequent false positive [18F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques
Milos D. Ikonomovic et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Patterns and severity of vascular amyloid in Alzheimer's disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer's disease
David M. A. Mann et al.
ACTA NEUROPATHOLOGICA (2018)
Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition
Ann D. Cohen et al.
ALZHEIMERS & DEMENTIA (2018)
Down syndrome, beta-amyloid and neuroimaging
Elizabeth Head et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome
Natalie Neale et al.
NEUROIMAGE-CLINICAL (2018)
The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer's disease in individuals with Down syndrome
Yvonne S. Davidson et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition
Dietmar Rudolf Thal et al.
ACTA NEUROPATHOLOGICA (2018)
Robust Motion Correction Strategy for Structural MRI in Unsedated Children Demonstrated with Three-dimensional Radial MPnRAGE
Steven Kecskemeti et al.
RADIOLOGY (2018)
PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI)
Michael S. Rafii et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
The Down syndrome brain in the presence and absence of fibrillar β-amyloidosis
Tiina Annus et al.
NEUROBIOLOGY OF AGING (2017)
Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline
James H. Cole et al.
NEUROBIOLOGY OF AGING (2017)
Cognitive decline and brain amyloid-β accumulation across 3 years in adults with Down syndrome
Sigan L. Hartley et al.
NEUROBIOLOGY OF AGING (2017)
Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespan
Harry LeVine et al.
NEUROBIOLOGY OF AGING (2017)
Small-molecule PET Tracers for Imaging Proteinopathies
Chester A. Mathis et al.
SEMINARS IN NUCLEAR MEDICINE (2017)
Cerebrovascular pathology in Down syndrome and Alzheimer disease
Elizabeth Head et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease
Maria Carmona-Iragui et al.
ALZHEIMERS & DEMENTIA (2017)
Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology
Elizabeth Head et al.
CURRENT ALZHEIMER RESEARCH (2016)
The pattern of amyloid accumulation in the brains of adults with Down syndrome
Tiina Annus et al.
ALZHEIMERS & DEMENTIA (2016)
The effects of normal aging on amyloid-β deposition in nondemented adults with Down syndrome as imaged by carbon 11-labeled Pittsburgh compound B
Patrick J. Lao et al.
ALZHEIMERS & DEMENTIA (2016)
Detection of Striatal Amyloid Plaques with [18F]flutemetamol: Validation with Postmortem Histopathology
Thomas G. Beach et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Post-mortem histopathology underlying β-amyloid PET imaging following flutemetamol F 18 injection
Milos D. Ikonomovic et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia
Marwan N. Sabbagh et al.
ALZHEIMERS & DEMENTIA (2015)
Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
Osama Sabri et al.
ALZHEIMERS & DEMENTIA (2015)
Amyloid β Accumulation Assessed with 11C-Pittsburgh Compound B PET and Postmortem Neuropathology
Hiroyuki Hatsuta et al.
CURRENT ALZHEIMER RESEARCH (2015)
Age dependence of brain β-amyloid deposition in Down syndrome An [18F]florbetaben PET study
Danna Jennings et al.
NEUROLOGY (2015)
Phase 3 Trial of Flutemetamol Labeled With Radioactive Fluorine 18 Imaging and Neuritic Plaque Density
Craig Curtis et al.
JAMA NEUROLOGY (2015)
Cognitive functioning in relation to brain amyloid-β in healthy adults with Down syndrome
Sigan L. Hartley et al.
BRAIN (2014)
Regional analysis of striatal and cortical amyloid deposition in patients with Alzheimer's disease
Kenji Ishibashi et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2014)
Pyroglutamate-3 Amyloid-β Deposition in the Brains of Humans, Non-Human Primates, Canines, and Alzheimer Disease-Like Transgenic Mouse Models
Jeffrey L. Frost et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study
Milos D. Ikonomovic et al.
ACTA NEUROPATHOLOGICA (2012)
Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B
Benjamin L. Handen et al.
ALZHEIMERS & DEMENTIA (2012)
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study (vol 11, pg 669, 2012)
C. M. Clark et al.
LANCET NEUROLOGY (2012)
Ante mortem amyloid imaging and β-amyloid pathology in a case with dementia with Lewy bodies
Kejal Kantarci et al.
NEUROBIOLOGY OF AGING (2012)
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
Christopher M. Clark et al.
LANCET NEUROLOGY (2012)
Positron Emission Tomography and Neuropathologic Estimates of Fibrillar Amyloid-β in a Patient With Down Syndrome and Alzheimer Disease
Marwan N. Sabbagh et al.
ARCHIVES OF NEUROLOGY (2011)
In Vivo Fibrillar β-Amyloid Detected Using [11C]PiB Positron Emission Tomography and Neuropathologic Assessment in Older Adults
Jitka Sojkova et al.
ARCHIVES OF NEUROLOGY (2011)
Using Positron Emission Tomography and Carbon 11-Labeled Pittsburgh Compound B to Image Brain Fibrillar β-Amyloid in Adults With Down Syndrome Safety, Acceptability, and Feasibility
Jennifer Landt et al.
ARCHIVES OF NEUROLOGY (2011)
Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease
Ahmadul Kadir et al.
BRAIN (2011)
Use of Florbetapir-PET for Imaging β-Amyloid Pathology
Christopher M. Clark et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease
Rebecca F. Rosen et al.
ACTA NEUROPATHOLOGICA (2010)
18F-Flutemetamol Amyloid Imaging in Alzheimer Disease and Mild Cognitive Impairment A Phase 2 Trial
Rik Vandenberghe et al.
ANNALS OF NEUROLOGY (2010)
Down's Syndrome: Up-Regulation of β-Amyloid Protein Precursor and τ mRNAs and Their Defective Coordination
Fumitaka Oyama et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Characteristics of Dyshoric Capillary Cerebral Amyloid Angiopathy
Edo Richard et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)
In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand F-18-AV-45 (Flobetapir F 18)
Dean F. Wong et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia
M. A. Burack et al.
NEUROLOGY (2010)
Cerebral amyloid angiopathy-related hemorrhage in a middle-aged patient with Down's syndrome
Ko-Suke Naito et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2008)
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Milos D. Ikonomovic et al.
BRAIN (2008)
PIB is a non-specific imaging marker of amyloid-beta (Aβ) peptide-related cerebral amyloidosis
A. Lockhart et al.
BRAIN (2007)
Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees
William E. Klunk et al.
JOURNAL OF NEUROSCIENCE (2007)
Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology
M. L. Margallo-Lana et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2007)
Molecular imaging with Pittsburgh compound B confirmed at autopsy - A case report
Brian J. Bacskai et al.
ARCHIVES OF NEUROLOGY (2007)
Characterization of Aβ11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains:: implication of N-terminally truncated Aβ species in the pathogenesis of Alzheimer's disease
Kangning Liu et al.
ACTA NEUROPATHOLOGICA (2006)
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
WE Klunk et al.
ANNALS OF NEUROLOGY (2004)
Parallel compensatory and pathological events associated with Tau pathology in middle aged individuals with Down Syndrome
E Head et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: Amphetamine-induced dopamine release in the functional subdivisions of the striatum
D Martinez et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2003)
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
DR Thal et al.
NEUROLOGY (2002)
Intraneuronal Aβ42 accumulation in Down syndrome brain
C Mori et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2002)
Imaging human mesolimbic dopamine transmission with positron emission tomography:: I.: Accuracy and precision of D2 receptor parameter measurements in ventral striatum
O Mawlawi et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2001)
Amyloid β protein (Aβ) starts to deposit as plasma membrane-bound form in diffuse plaques of brains from hereditary cerebral hemorrhage with amyloidosis-Dutch type, Alzheimer disease and nondemented aged subjects
H Yamaguchi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)
Structural studies of soluble oligomers of the Alzheimer β-amyloid peptide
THJ Huang et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
X-34, a fluorescent derivative of Congo red: A novel histochemical stain for Alzheimer's disease pathology
SC Styren et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2000)
分享论文
